Hints and tips:
...A gambit to raise cash for US rival Carlyle Group’s latest buyout fund has come up short....
...It was the largest bond sale in the US since March 2011, when Sanofi-Aventis sold $7bn, Dealogic said....
...He also has served on the board of Genzyme, the biotech company sold to Sanofi-Aventis this year for more than $20bn....
...In a research note on Monday, Cowen argued that a number of the large pharmaceutical groups, led by Eli Lilly, Sanofi-Aventis and Pfizer, would be worth more if they divested separable business units, which...
...Sanofi-Aventis has replaced its top executive in charge of research and development with a radiologist and former head of the US’s largest public funding body for medical research....
...Sanofi-Aventis has continued aggressively to acquire others, including ultimately winning support for the takeover of US group Genzyme after raising its bid above $20bn....
...Diabetes medications still make up about 17 per cent of Lilly’s $22bn revenues, but in recent years it has lost ground to rivals such as Merck and Sanofi-Aventis....
...Sanofi-Aventis stepped up its pursuit of Genzyme on Sunday, outlining publicly its interest in a takeover deal as it inched closer to making a hostile offer for the US biotech company....
...High factory automation has helped contain V-Zug’s costs, including a smart new computerised logistics centre opened this year. “Productivity is a key success factor for us,” Mr Buhofer says....
...In pharmaceuticals, the government engineered the merger between Sanofi and Aventis to create a new champion rather than allow the Swiss Novartis to swallow it up....
...“Regulators are generally a bit conservative and want to develop more experience,” says Li Zheng from Sanofi-Aventis....
...A study by a British medical journal reported that a blood-thinning pill developed by the company worked better than Plavix, a rival drug made by Sanofi-Aventis....
...The World Health Organisation on Monday said that leading vaccine producers including Novartis, GlaxoSmithKline and Sanofi-Aventis had requested “wild type virus” samples of the A (H1N1) virus....
...Then again, now that the Dutch group has flagged its interest in a takeover, Sanofi-Aventis and its rivals may come back with counter offers....
...Bernstein saw Bristol-Myers Squibb, GlaxoSmithKline and Sanofi Aventis among potential buyers of the franchise....
...His appointment comes as GlaxoSmithKline also seeks a new US head of operations, following the recent departure of Chris Viehbacher, who takes over as chief executive of Sanofi-Aventis of France at the start...
...Swiss drugmaker Novartis gained 23.7 per cent to SFr59.50 while in France, Sanofi-Aventis climbed 17.2 per cent to €44.44. Germany’s BMW was boosted by an upgrade from Goldman Sachs....
...Mr Buffett also added to his positions in Ingersoll-Rand, a maker of refrigeration gear, and Sanofi Aventis, the French drugmaker....
...Sanofi-Aventis is currently bidding against a rival consortium to buy control of Zentiva, a Czech generic drugs manufacturer, as it expands its franchise into eastern and central Europe, where generics are...
...The rethink is another sign that Berlin is feeling its way towards an unabashed industrial policy, in the face of French state intervention in Franco-German aerospace group EADS or the drugs merger Sanofi-Aventis...
...Merck and Lundbeck discontinued Gaboxadol’s development, a move which Datamonitor, the research company, predicts will leave the field clear for Sanofi-Aventis, which controls more than half the world market...
...Shares in Bristol-Myers Squibb fell 3.3 per cent to $27.59 after reports of a break-down in the merger talks with Sanofi-Aventis ....
...Sanofi-Aventis, the pharmaceutical group formed when Sanofi Synthelabo merged with Aventis in 2004 after the French government intervened to warn off Novartis, bought a 19.6 per cent stake from Warburg Pincus...
...But Friday’s sale comes after the Kuwait Petroleum Corporation (KPC) last year reduced its 13.5 per cent stake in Aventis following the takeover by Franco-German group Sanofi-Synthelabo....
International Edition